Individual Variability in Reaction Time and Prediction of Clinical Response to Methylphenidate in Adult ADHD: A Prospective Open Label Study Using Conners’ Continuous Performance Test II

Abstract

Objective: The aim of this study was to examine whether reaction time parameters in adult patients with ADHD could predict their response to methylphenidate (MPH). Method: Previously unmedicated patients (N = 123) were administered the Conners’ Continuous Performance Test II (CPT II) at baseline and after 6 weeks of treatment with immediate-release MPH. In addition to traditional CPT measures, we extracted intraindividual raw data and analyzed time series using linear and nonlinear mathematical models. Results: Clinical responders, assessed with the Clinical Global Impression-Improvement scale, showed significant normalization of target failures, reduced variability and skewness, and increased complexity of reaction time series after 6 weeks of treatment, while nonresponders showed no significant changes. Prior to treatment, responders had significantly higher variability and skewness, combined with lower complexity, compared with nonresponders. Conclusion: These results show that the CPT test is useful in the evaluation of treatment response to MPH.

Keywords

adult ADHD treatment reaction time intrasubject variability continuous performance test methylphenidate

Get full access to this article

View all access options for this article.

References

Abikoff

Arnold

L. E.

Newcorn

J. H.

Elliott

G. R.

Hechtman

Severe

J. B.

. . . Wells

K. C.

(2002). Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: The MTA manual-based solution. Journal of the American Academy of Child & Adolescent Psychiatry, 41, 498-504.

American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.

American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.

Barkley

R. A.

(2010). Differential diagnosis of adults with ADHD: The role of executive function and self-regulation. Journal of Clinical Psychiatry, 71, e17. doi:10.4088/JCP.9066tx1c

Barkley

R. A.

Edwards

Laneri

Fletcher

Metevia

(2001). Executive functioning, temporal discounting, and sense of time in adolescents with attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD). Journal of Abnormal Child Psychology, 29, 541-556.

Biederman

Faraone

S. V.

(2005). Attention-deficit hyperactivity disorder. The Lancet, 366, 237-248. doi:10.1016/s0140-6736(05)66915-2

Biederman

Mick

Surman

Doyle

Hammerness

Kotarski

Spencer

(2010). A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology, 30, 549-553. doi:10.1097/JCP.0b013e3181ee84a7

Biederman

Petty

C. R.

Evans

Small

Faraone

S. V.

(2010). How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Research, 177, 299-304. doi:S0165-1781(09)00519-8

10.

Biederman

Petty

C. R.

Fried

Fontanella

Doyle

A. E.

Seidman

L. J.

Faraone

S. V.

(2006). Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry, 163, 1730-1738. doi:163/10/1730

11.

Biederman

Petty

C. R.

O’Connor

K. B.

Hyder

L. L.

Faraone

S. V.

(2012). Predictors of persistence in girls with attention deficit hyperactivity disorder: Results from an 11-year controlled follow-up study. Acta Psychiatrica Scandinavica, 125, 147-156. doi:10.1111/j.1600-0447.2011.01797.x

12.

Buitelaar

J. K.

Kooij

J. J.

Ramos-Quiroga

J. A.

Dejonckheere

Casas

van Oene

J. C.

. . . Trott

G. E.

(2011). Predictors of treatment outcome in adults with ADHD treated with OROS(R) methylphenidate. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35, 554-560. doi:S0278-5846(10)00510-5

13.

Buitelaar

J. K.

Van Der Gaag

R. J.

Swaab-barnkvhld

Kuipkr

M. A.

(1995). Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 34, 1025-1032. doi:10.1080/15374416.2016.1228461

14.

Busner

Targum

S. D.

(2007). The clinical global impressions scale: Applying a research tool in clinical practice. Psychiatry (Edgmont), 4, 28-37.

15.

Castellanos

F. X.

Sonuga-Barke

E. J.

Milham

M. P.

Tannock

(2006). Characterizing cognition in ADHD: Beyond executive dysfunction. Trends Cognitive Sciences, 10, 117-123. doi:10.1016/j.tics.2006.01.011

16.

Castellanos

F. X.

Sonuga-Barke

E. J.

Scheres

M. A.

Hyde

Walters

J. R.

(2005). Varieties of attention-deficit/hyperactivity disorder-related intra-individual variability. Biological Psychiatry, 57, 1416-1423.

17.

Chazan

Borowski

Pianca

Ludwig

Rohde

L. A.

Polanczyk

(2011). Do phenotypic characteristics, parental psychopathology, family functioning, and environmental stressors have a role in the response to methylphenidate in children with attention-deficit/hyperactivity disorder? A naturalistic study from a developing country. Journal of Clinical Psychopharmacology, 31, 309-317. doi:10.1097/JCP.0b013e318217b4df

18.

Coghill

D. R.

Nigg

Rothenberger

Sonuga-Barke

Tannock

(2005). Whither causal models in the neuroscience of ADHD? Developmental Science, 8, 105-114. doi:10.1111/j.1467-7687.2005.00397.x

19.

Coghill

D. R.

Rhodes

S. M.

Matthews

(2007). The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder. Biological Psychiatry, 62, 954-962. doi:10.1016/j.biopsych.2006.12.030

20.

Coghill

D. R.

Seth

Matthews

(2014). A comprehensive assessment of memory, delay aversion, timing, inhibition, decision making and variability in attention deficit hyperactivity disorder: Advancing beyond the three-pathway models. Psychological Medicine, 44, 1989-2001. doi:10.1017/s0033291713002547

21.

Conners

C. K.

Eisenberg

Barcai

(1967). Effect of dextroamphetamine on children. Studies on subjects with learning disabilities and school behavior problems. Archives of General Psychiatry, 17, 478-485. doi:10.1001/archpsyc.1967.01730280094011

22.

Conners

C. K.

Epstein

J. N.

Angold

Klaric

(2003). Continuous performance test performance in a normative epidemiological sample. Journal of Abnormal Child Psychology, 31, 555-562. doi:10.1023/A:1025457300409

23.

Conners

C. K.

Staff

Connelly

Campbell

MacLean

Barnes

(2000). Conners’ continuous performance Test II (CPT II v. 5). Multi-Health Systems Inc, 29, 175-196.

24.

Cunill

Castells

Tobias

Capellà

(2016). Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: A meta-analysis and meta-regression in over 9000 patients. Psychopharmacology, 233, 187-197. doi:10.1007/s00213-015-4099-3

25.

del Campo

Chamberlain

S. R.

Sahakian

B. J.

Robbins

T. W

. (2011). The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biological Psychiatry, 69, e145-e157. doi:10.1016/j.biopsych.2011.02.036

26.

Egeland

Kovalik-Gran

(2010). Validity of the factor structure of Conners’ CPT. Journal of Attention Disorders, 13, 347-357. doi:1087054709332477

27.

Epstein

J. N.

Erkanli

Conners

C. K.

Klaric

Costello

J. E.

Angold

(2003). Relations between Continuous Performance Test performance measures and ADHD behaviors. Journal of Abnormal Child Psychology, 31, 543-554. doi:10.1023/A:1025405216339

28.

Faraone

S. V.

Biederman

Mick

(2006). The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of follow-up studies. Psychological Medicine, 36, 159-165. doi:10.1017/S003329170500471X

29.

Faraone

S. V.

Glatt

S. J.

(2010). A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. Journal of Clinical Psychiatry, 71, 754-763. doi:10.4088/JCP.08m04902pur

30.

Fasmer

O. B.

Mjeldheim

Førland

Hansen

A. L.

Syrstad

V. E. G.

Oedegaard

K. J.

Berle

J. Ø

. (2016). Linear and non-linear analyses of Conner’s continuous performance test-II discriminate adult patients with attention deficit hyperactivity disorder from patients with mood and anxiety disorders. BMC Psychiatry, 16, Article 284. doi:10.1186/s12888-016-0993-4

31.

Fredriksen

Dahl

A. A.

Martinsen

E. W.

Klungsoyr

Faraone

S. V.

Peleikis

D. E.

(2014). Childhood and persistent ADHD symptoms associated with educational failure and long-term occupational disability in adult ADHD. Attention Deficit and Hyperactivity Disorders, 6, 87-99. doi:10.1007/s12402-014-0126-1

32.

Fredriksen

Dahl

A. A.

Martinsen

E. W.

Klungsoyr

Haavik

Peleikis

D. E.

(2014). Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): An open-label prospective study of time in treatment, dose, side-effects and comorbidity. European Neuropsychopharmacology, 24, 1873-1884.

33.

Fredriksen

Halmoy

Faraone

S. V.

Haavik

(2013). Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: A review of controlled and naturalistic studies. European Neuropsychopharmacology, 23, 508-527.

34.

Garrett

D. D.

Kovacevic

McIntosh

A. R.

Grady

C. L.

(2010). Blood oxygen level-dependent signal variability is more than just noise. Journal of Neuroscience, 30, 4914-4921.

35.

Goldberger

A. L.

Amaral

L. A.

Glass

Hausdorff

J. M.

Ivanov

P. C.

Mark

R. G.

. . . Stanley

H. E.

(2000). Physiobank, physiotoolkit, and physionet. Circulation, 101, e215-e220.

36.

Guy

(1976). ECDEU assessment manual for psychopharmacology (Vol. 76). Rockville, Md: U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs.

37.

Guzzetti

Borroni

Garbelli

P. E.

Ceriani

Della Bella

Montano

. . . Porta

(2005). Symbolic dynamics of heart rate variability. Circulation, 112, 465-470. doi:10.1161/CIRCULATIONAHA.104.518449

38.

Haavik

Halmoy

Lundervold

A. J.

Fasmer

O. B.

(2010). Clinical assessment and diagnosis of adults with attention-deficit/hyperactivity disorder. Expert Review of Neurotherapeutics, 10, 1569-1580. doi:10.1586/ern.10.149

39.

Hart

Chantiluke

Cubillo

A. I.

Smith

A. B.

Simmons

Brammer

M. J.

. . . Rubia

(2014). Pattern classification of response inhibition in ADHD: Toward the development of neurobiological markers for ADHD. Human Brain Mapping, 35, 3083-3094. doi:10.1002/hbm.22386

40.

Hauge

E. R.

Berle

J. Ø.

Oedegaard

K. J.

Holsten

Fasmer

O. B.

(2011). Nonlinear analysis of motor activity shows differences between schizophrenia and depression: A study using Fourier analysis and sample entropy. PLoS ONE, 6, e16291. doi:10.1371/journal.pone.0016291

41.

Ishii-Takahashi

Takizawa

Nishimura

Kawakubo

Hamada

Okuhata

. . . Todokoro

(2015). Neuroimaging-aided prediction of the effect of methylphenidate in children with attention-deficit hyperactivity disorder: A randomized controlled trial. Neuropsychopharmacology, 40, 2676-2685. doi:10.1038/npp.2015.128

42.

Johnson

K. A.

Barry

Bellgrove

M. A.

Cox

Kelly

S. P.

Dáibhis

. . . Fitzgerald

(2008). Dissociation in response to methylphenidate on response variability in a group of medication naive children with ADHD. Neuropsychologia, 46, 1532-1541. doi:10.1016/j.neuropsychologia.2008.01.002

43.

Johnson

K. A.

Kelly

S. P.

Bellgrove

M. A.

Barry

Cox

Gill

Robertson

I. H.

(2007). Response variability in attention deficit hyperactivity disorder: Evidence for neuropsychological heterogeneity. Neuropsychologia, 45, 630-638. doi:10.1016/j.neuropsychologia.2006.03.034

44.

Johnston

B. A.

Coghill

Matthews

Steele

J. D.

(2015). Predicting methylphenidate response in attention deficit hyperactivity disorder: A preliminary study. Journal of Psychopharmacology, 29, 24-30. doi:10.1177/0269881114548438

45.

Kaasinen

Rinne

J. O.

(2002). Functional imaging studies of dopamine system and cognition in normal aging and Parkinson’s disease. Neuroscience & Biobehavioral Reviews, 26, 785-793.

46.

Kaiser

Roth

Rentrop

Friederich

H.-C.

Bender

Weisbrod

(2008). Intra-individual reaction time variability in schizophrenia, depression and borderline personality disorder. Brain and Cognition, 66, 73-82. doi:10.1016/j.bandc.2007.05.007

47.

Kessler

R. C.

Adler

L. A.

Barkley

Biederman

Conners

C. K.

Faraone

S. V.

. . . Zaslavsky

A. M.

(2005). Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: Results from the national comorbidity survey replication. Biological Psychiatry, 57, 1442-1451.

48.

Kim

J.-W.

Sharma

Ryan

N. D.

(2015). Predicting methylphenidate response in ADHD using machine learning approaches. International Journal of Neuropsychopharmacology, 18, pyv052. doi:10.1093/ijnp/pyv052

49.

Kofler

M. J.

Rapport

M. D.

Sarver

D. E.

Raiker

J. S.

Orban

S. A.

Friedman

L. M.

Kolomeyer

E. G.

(2013). Reaction time variability in ADHD: A meta-analytic review of 319 studies. Clinical Psychology Review, 33, 795-811. doi:10.1016/j.cpr.2013.06.001

50.

Kooij

J. J. S.

Burger

Boonstra

A. M.

Van der Linden

P. D.

Kalma

L. E.

Buitelaar

J. K.

(2004). Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder: A randomized placebo-controlled double-blind cross-over trial. Psychological Medicine, 34, 973-982.

51.

Kooij

J. J. S.

(2012). Diagnostic assessment and treatment. Adult ADHD. 3rd ed. London: Springer-Verlag. doi:10.1007/978-1-4471-4138-9

52.

Lara

Fayyad

G. R.

Kessler

R. C.

Aguilar-Gaxiola

Angermeyer

. . . Sampson

(2009). Childhood predictors of adult attention-deficit/hyperactivity disorder: Results from the World Health Organization World Mental Health Survey Initiative. Biological Psychiatry, 65, 46-54.

53.

Lee

R. W.

Jacobson

L. A.

Pritchard

A. E.

Ryan

M. S.

Denckla

M. B.

. . . Mahone

E. M.

(2015). Jitter reduces response-time variability in ADHD: An ex-Gaussian analysis. Journal of Attention Disorders, 19, 794-804. doi:10.1177/1087054712464269

54.

Lee

S. H.

Song

D. H.

Kim

B. N.

Joung

Y. S.

E. H.

Cheon

K. A.

. . . Shin

D. W.

(2009). Variability of response time as a predictor of methylphenidate treatment response in Korean children with attention deficit hyperactivity disorder. Yonsei Medical Journal, 50, 650-655. doi:10.3349/ymj.2009.50.5.650

55.

Lloyd

Hodgkins

Sasane

Akehurst

Sonuga-Barke

E. J.

Fitzgerald

. . . Brazier

(2011). Estimation of utilities in attention-deficit hyperactivity disorder for economic evaluations. Patient, 4, 247-257. doi:10.2165/11592150-000000000-00000

56.

Losier

B. J.

McGrath

P. J.

Klein

R. M.

(1996). Error patterns on the continuous performance test in non medicated and medicated samples of children with and without ADHD: A meta analytic review. Journal of Child Psychology and Psychiatry, 37, 971-987.

57.

MacDonald

S. W.

Nyberg

Bäckman

(2006). Intra-individual variability in behavior: Links to brain structure, neurotransmission and neuronal activity. Trends in Neurosciences, 29, 474-480. doi:10.1016/j.tins.2006.06.011

58.

McIntosh

A. R.

Kovacevic

Itier

R. J.

(2008). Increased brain signal variability accompanies lower behavioral variability in development. PLoS Computational Biology, 4(7), e1000106. doi:10.1371/journal.pcbi.1000106

59.

McMahon

F. J.

(2014). Prediction of treatment outcomes in psychiatry—Where do we stand? Dialogues in Clinical Neuroscience, 16, 455.

60.

Moffitt

T. E.

Houts

Asherson

Belsky

D. W.

Corcoran

D. L.

Hammerle

. . . Polanczyk

G. V.

(2015). Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study. American Journal of Psychiatry, 172, 967-977. doi:10.1176/appi.ajp.2015.14101266

61.

Morris

S. B.

DeShon

R. P.

(2002). Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. Psychological Methods, 7, 105-125.

62.

Mowinckel

A. M.

Alnaes

Pedersen

M. L.

Ziegler

Fredriksen

Kaufmann

. . . Biele

(2017). Increased default-mode variability is related to reduced task-performance and is evident in adults with ADHD. Neuroimage: Clinical, 16, 369-382. doi:10.1016/j.nicl.2017.03.008

63.

Mujica-Parodi

Yeragani

Malaspina

(2005). Nonlinear complexity and spectral analyses of heart rate variability in medicated and unmedicated patients with schizophrenia1. Neuropsychobiology, 51, 10-15. doi:10.1159/000082850

64.

Nigg

J. T.

(2013). Attention-deficit/hyperactivity disorder and adverse health outcomes. Clinical Psychology Review, 33, 215-228. doi:10.1016/j.cpr.2012.11.005

65.

Noreika

Falter

C. M.

Rubia

(2013). Timing deficits in attention-deficit/hyperactivity disorder (ADHD): Evidence from neurocognitive and neuroimaging studies. Neuropsychologia, 51, 235-266. doi:10.1016/j.neuropsychologia.2012.09.036

66.

Park

Kim

B. N.

Cho

S. C.

Kim

J. W.

Shin

M. S.

Yoo

H. J.

. . . Cheong

J. H.

(2013). Baseline severity of parent-perceived inattentiveness is predictive of the difference between subjective and objective methylphenidate responses in children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 23, 410-414. doi:10.1089/cap.2013.0031

67.

Perry

G. M.

Sagvolden

Faraone

S. V.

(2010). Intraindividual variability (IIV) in an animal model of ADHD-the Spontaneously Hypertensive Rat. Behavioral and Brain Functions, 6, Article 56. doi:10.1186/1744-9081-6-56

68.

Polanczyk

de Lima

M. S.

Horta

B. L.

Biederman

Rohde

L. A.

(2007). The worldwide prevalence of ADHD: A systematic review and metaregression analysis. American Journal of Psychiatry, 164, 942-948.

69.

Porta

Tobaldini

Guzzetti

Furlan

Montano

Gnecchi-Ruscone

(2007). Assessment of cardiac autonomic modulation during graded head-up tilt by symbolic analysis of heart rate variability. American Journal of Physiology-Heart and Circulatory Physiology, 293, 702-708. doi:10.1152/ajpheart.00006.2007

70.

Rabin

L. A.

Spadaccini

A. T.

Brodale

D. L.

Grant

K. S.

Elbulok-Charcape

M. M.

Barr

W. B.

(2014). Utilization rates of computerized tests and test batteries among clinical neuropsychologists in the United States and Canada. Professional Psychology: Research and Practice, 45, 368. doi:10.1037/a0037987

71.

Riccio

C. A.

Waldrop

J. J.

Reynolds

C. R.

Lowe

(2001). Effects of stimulants on the continuous performance test (CPT): Implications for CPT use and interpretation. The Journal of Neuropsychiatry and Clinical Neurosciences, 13, 326-335. doi:10.1176/jnp.13.3.326

72.

Richman

J. S.

Moorman

J. R.

(2000). Physiological time-series analysis using approximate entropy and sample entropy. American Journal of Physiology-Heart and Circulatory Physiology, 278, 2039-2049. doi:10.1152/ajpheart.2000.278.6.H2039

73.

Rosch

K. S.

Dirlikov

Mostofsky

S. H.

(2015). Reduced intrasubject variability with reinforcement in boys, but not girls, with ADHD: Associations with prefrontal anatomy. Biological Psychology, 110, 12-23. doi:10.1016/j.biopsycho.2015.06.010

74.

Rosler

Fischer

Ammer

Ose

Retz

(2009). A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. European Archives of Psychiatry and Clinical Neuroscience, 259, 120-129. doi:10.1007/s00406-008-0845-4

75.

Rosvold

H. E.

Mirsky

A. F.

Sarason

Bransome

E. D.

Jr. Beck

L. H.

(1956). A continuous performance test of brain damage. Journal of Consulting Psychology, 20, 343-350.

76.

Schrantee

Tamminga

H. G.

Bouziane

Bottelier

M. A.

Bron

E. E.

Mutsaerts

H.-J. M.

. . . Lindauer

R. J.

(2016). Age-dependent effects of methylphenidate on the human dopaminergic system in young vs adult patients with attention-deficit/hyperactivity disorder: A randomized clinical trial. JAMA Psychiatry, 73, 955-962. doi:10.1001/jamapsychiatry.2016.1572

77.

Sergeant

J. A.

Geurts

Huijbregts

Scheres

Oosterlaan

(2003). The top and the bottom of ADHD: A neuropsychological perspective. Neuroscience & Biobehavioral Reviews, 27, 583-592.

78.

Setyawan

Fridman

Hodgkins

Quintero

Erder

M. H.

Katić

B. J.

Harpin

(2015). Relationship between symptom impairment and treatment outcome in children and adolescents with attention-deficit/hyperactivity disorder: A physician perspective. ADHD Attention Deficit and Hyperactivity Disorders, 7, 75-87. doi:10.1007/s12402-014-0143-0

79.

Sheehan

Janavs

Baker

Harnett-Sheehan

Knapp

Sheehan

(2002). MINI PLUS. Mini international neuropsychiatric interview (Norwegian version). Tampa: Institute for Research in Psychiatry, University of South Florida.

80.

Stuhec

Munda

Svab

Locatelli

(2015). Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: A meta-analysis with focus on bupropion. Journal of Affective Disorders, 178, 149-159. doi:10.1016/j.jad.2015.03.006

81.

Treuer

Feng

Desaiah

Altin

El-Shafei

. . . Faries

(2014). Predictors of pharmacological treatment outcomes with atomoxetine or methylphenidate in patients with attention-deficit/hyperactivity disorder from China, Egypt, Lebanon, Russian Federation, Taiwan, and United Arab Emirates. International Journal of Clinical Practice, 68, 1152-1160. doi:10.1111/ijcp.12437

82.

Urban

K. R.

Gao

W.-J.

(2015). Evolution of the study of methylphenidate and its actions on the adult versus juvenile brain. Journal of Attention Disorders, 19, 603-619. doi:10.1177/1087054712455504

83.

Vaurio

R. G.

Simmonds

D. J.

Mostofsky

S. H.

(2009). Increased intra-individual reaction time variability in attention-deficit/hyperactivity disorder across response inhibition tasks with different cognitive demands. Neuropsychologia, 47, 2389-2396. doi:10.1016/j.neuropsychologia.2009.01.022

84.

Vitola

E. S.

Bau

C. H.

Salum

G. A.

Horta

B. L.

Quevedo

Barros

F. C.

. . . Grevet

E. H.

(2017). Exploring DSM-5 ADHD criteria beyond young adulthood: Phenomenology, psychometric properties and prevalence in a large three-decade birth cohort. Psychological Medicine, 47, 744-754. doi:10.1017/s0033291716002853

85.

Wasserstein

(2005). Diagnostic issues for adolescents and adults with ADHD. Journal of Clinical Psychology, 61, 535-547. doi:10.1002/jclp.20118

86.

Willcutt

E. G.

Nigg

J. T.

Pennington

B. F.

Solanto

M. V.

Rohde

L. A.

Tannock

. . . Lahey

B. B.

(2012). Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes. Journal of Abnormal Psychology, 121, 991-1010.

87.

Wong

H. K.

Tiffin

P. A.

Chappell

M. J.

Nichols

T. E.

Welsh

P. R.

Doyle

O. M.

. . . Shen

(2017). Personalized medication response prediction for attention-deficit hyperactivity disorder: Learning in the model space vs. learning in the data space. Frontiers in Physiology, 11, Article 199. doi:10.3389/fphys.2017.00199

88.

Zhuang

Ning

Wang

Huo

Yang

Fan

(2008). Nonlinear short-term heart rate variability prediction of spontaneous ventricular tachyarrhythmia. Chinese Science Bulletin, 53, 2446-2453.

89.

Zweig

M. H.

Campbell

(1993). Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clinical Chemistry, 39, 561-577.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.57 MB